About Genoptix
Genoptix is a company based in Carlsbad (United States) founded in 1999 by Tina S Nova and Gene Tu was acquired by NeoGenomics in October 2018.. Genoptix has raised $33.26 million across 7 funding rounds from investors including Novartis, Comerica and NeoGenomics. The company has 46 employees as of December 31, 2018. Genoptix has completed 2 acquisitions, including HistoRx and Rosetta Genomics. Genoptix operates in a competitive market with competitors including Abingdon Health, Precipio Diagnostics, SkylineDX, Elucida Oncology and JaxBio, among others.
- Headquarter Carlsbad, United States
- Employees 46 as on 31 Dec, 2018
- Founders Tina S Nova, Gene Tu
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Genoptix, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Genoptix
Genoptix has successfully raised a total of $33.26M across 7 strategic funding rounds. The most recent funding activity was a Series D round of $17.3 million completed in August 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series D — $17.3M
-
First Round
First Round
(22 Nov 2002)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2005 | Amount | Series D - Genoptix | Valuation |
investors |
|
| Sep, 2004 | Amount | Series C - Genoptix | Valuation |
investors |
|
| Oct, 2003 | Amount | Series B - Genoptix | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Genoptix
Genoptix has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Novartis, Comerica and NeoGenomics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm investing in the US
|
Founded Year | Domain | Location | |
|
Healthcare investments are made by Tullis Health Investors.
|
Founded Year | Domain | Location | |
|
Expansion and growth capital is provided by 1315 Capital to healthcare companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Genoptix
Genoptix has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include HistoRx and Rosetta Genomics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Tissue-based diagnostic solutions for research and clinical pathology markets
|
2001 | ||||
|
Genetic tests for cancer diagnosis and profiling are developed.
|
2000 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Genoptix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Genoptix Comparisons
Competitors of Genoptix
Genoptix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abingdon Health, Precipio Diagnostics, SkylineDX, Elucida Oncology and JaxBio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of immunoassays for diagnostic purposes
|
|
| domain | founded_year | HQ Location |
Cancer diagnostics and second opinion tools are offered.
|
|
| domain | founded_year | HQ Location |
Gene expression profiling tests are provided for personalized medicine.
|
|
| domain | founded_year | HQ Location |
Nanotechnology-based particle delivery platform is developed for oncology applications.
|
|
| domain | founded_year | HQ Location |
Developer of an AI-based chip for genetic and epigenetic profiling
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Genoptix
Frequently Asked Questions about Genoptix
When was Genoptix founded?
Genoptix was founded in 1999 and raised its 1st funding round 3 years after it was founded.
Where is Genoptix located?
Genoptix is headquartered in Carlsbad, United States. It is registered at Carlsbad, California, United States.
Who is the current CEO of Genoptix?
Joseph Limber is the current CEO of Genoptix.
Is Genoptix a funded company?
Genoptix is a funded company, having raised a total of $33.26M across 7 funding rounds to date. The company's 1st funding round was a Series B of $7.69M, raised on Nov 22, 2002.
How many employees does Genoptix have?
As of Dec 31, 2018, the latest employee count at Genoptix is 46.
What does Genoptix do?
Genoptix focussed on Oncology diagnostics and informatics services. It was the first licensee of AQUA technology (which it received by acquiring HistoRx) to perform clinical laboratory services for measurement of protein in tissue specimens. It has launched a series of breast cancer assays using this platform. It also provides comprehensive testing solutions to community oncologists and pathologists in hematology and solid tumor molecular profiling. It claims that it has the largest hematopathology center in US and is specialized in diagnosing cancers in bone marrow, blood and lymph nodes. It was acquired by Novartis in January 2011 for 470M and is currently serving as its subsidiary.
Who are the top competitors of Genoptix?
Genoptix's top competitors include Abingdon Health, Precipio Diagnostics and SkylineDX.
How many acquisitions has Genoptix made?
Genoptix has made 2 acquisitions, including HistoRx, and Rosetta Genomics.
Who are Genoptix's investors?
Genoptix has 7 investors. Key investors include Novartis, Comerica, NeoGenomics, Chicago Growth Partners, and Tullis Health Investors.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.